RU-486 Review Focus On "Intended Use" Is Appropriate - Henney

FDA approval of the abortifacient mifepristone (RU-486) is appropriate provided that the drug is safe and effective for its intended use by pregnant women for termination of pregnancy, FDA Commissioner nominee Jane Henney, MD, told the Senate Labor & Human Resources Committee Aug. 24.